The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Tite & Lewis, the firm linked to Ernst & Young (E&Y), has snatched a new international client from under the nose of Eversheds
The firm has just done its first piece of work for Japanese client Kowa Company, for whom it bought 5 per cent of the issued shares in UK-listed SkyePharma. SkyePharma was Kowa's first major UK acquisition, but the company has a UK branch and has previously used Eversheds for litigation work. But E&Y introduced Kowa to Tite & Lewis, which was doing due diligence on the SykePharma acquisition. The corporate team, led by partner Iain Young, completed the legal due diligence. Kowa then instructed Tite & Lewis on all corporate aspects. The acquisition of SkyePharma's shares was a precursor to a joint venture between the two companies for a drugs manufacturing plant in Lyon, France. The joint venture is expected to be announced this week and, according to Young, Kowa will instruct Tite & Lewis, making Kowa one of its most important clients. SkyePharma was represented by Stringer Saul and CMS Cameron McKenna, but Young said that Tite & Lewis hopes to secure the future corporate work on the French joint venture.